Tempus co-founder and CEO Eric Lefkofsky Photograph by Stuart Isett/Fortune Brainstorm Health

Tempus — a company led by Groupon co-founder and ex-CEO Eric Lefkofsky that gathers and analyses molecular and clinical data on cancer treatment from medical centers and hospitals, which is then offered to life sciences customers — has raised $200 million Series F funding that values it at $3.1 billion. This is up from a $2 billion valuation August last year.

Tempus has now raised a total of $520 million since inception in 2015. Investors including Baillie Gifford, NEA, Revolution Growth, Novo Holdings, Franklin Templeton and accounts managed by T. Rowe Price participated in this round. Tempus claims its data platform now reaches more than 1 in 4 cancer patients in the U.S.

Revolution Growth CEO and AOL co-founder Steve Case. Revolution Growth participated in this round. Case is also an advisor to Tempus. Photo by Steve Jennings/Getty Images for TechCrunch

Eric Lefkofsky who founded Tempus in 2015 has an impressive list of entrepreneurial successes. Not only did he back and formerly lead e-commerce marketplace Groupon, he also co-founded ad-tech company MediaBank, publicly traded supply chain company Echo Global Logistics, Chicago-based VC firm Lightbank and $2.3 billion valued big-data company Uptake.

Tempus’s current valuation makes it one of the highest valued private companies in the Chicago area, along with companies like Avant, SMS Assist, ExteNet and Raise.

Share this...

Facebook

Pinterest

Twitter

Linkedin

Whatsapp

Email

Print